Public-Private Consortium Formed for Early Stage Biotech Investment
7/21/2008 7:14:30 AM
iStockAnalyst -- A combination of public and private entities have banded together to form a loosely organized investment consortium that will focus on early stage biotech enterprises. The Biotech Science and Technology Venture Alliance combines 22 partners, some from industry, others from academia, including companies such as Shijiazhuang Pharmaceutical Group, DSM China and the Chinese Academy of Sciences (CAS).
comments powered by